Can Lipid-Lowering Drugs Reduce the Risk of Cholelithiasis? A Mendelian Randomization Study

Can Lipid-Lowering Drugs Reduce the Risk of Cholelithiasis? A Mendelian Randomization Study

Hao Dong,1,* Rong Chen,2,* Fang Xu,3,* Fang Cheng4 1Department of Gastroenterology and Hepatology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China; 2Department of Rehabilitation Medicine, the First Affiliated Hospital of S...

Full description

Bibliographic Details
Main Authors: Dong H, Chen R, Xu F, Cheng F
Format: Article
Language:English
Published: Dove Medical Press 2024-02-01
Series:Clinical Epidemiology
Subjects:
cholelithiasis
lipid-lowering drugs
mendelian randomization analysis
hmgcr inhibitors
pcsk9 inhibitors
npc1l1 inhibitors.
Online Access:https://www.dovepress.com/can-lipid-lowering-drugs-reduce-the-risk-of-cholelithiasis-a-mendelian-peer-reviewed-fulltext-article-CLEP

Internet

https://www.dovepress.com/can-lipid-lowering-drugs-reduce-the-risk-of-cholelithiasis-a-mendelian-peer-reviewed-fulltext-article-CLEP

Similar Items